After undergoing EVX-01 treatment, a significant and continuous tumor reduction was observed in a metastatic melanoma patient with initial progressive disease Key highlights of the initial Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback